Grantham, Mayo, Van Otterloo & Co (GMO)
AXNX

Grantham, Mayo, Van Otterloo & Co (GMO)’s Axonics, Inc. Common Stock AXNX Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio AXNX Stock Details AXNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-30,000
Closed -$2.09M – 627
2024
Q3 		$2.09M Buy
+30,000
New +$2.06M 0.01% 368

Other funds holding AXNX

TCA
Taconic Capital Advisors New York $229M AUM 110.07% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s AXNX Position: Q4 2024 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Axonics, Inc. Common Stock (AXNX) in Q4 2024, closing a stake of 30,000 shares — an estimated $2.09M sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in AXNX in Q3 2024 and held it in 1 quarter. The position peaked at $2.09M in Q3 2024. 2 funds tracked by Wall St. Rank hold AXNX as of Q4 2024.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Axonics, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 30,000 Axonics, Inc. Common Stock shares in Q4 2024, an estimated $2.09M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Axonics, Inc. Common Stock in Q3 2024 and held it in 1 quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Axonics, Inc. Common Stock position peaked at $2.09M in Q3 2024.
  • 2 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q4 2024.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q4 2024, filed 13 Feb 2025.